Entrada Therapeutics
Intracellular therapeutics for patients with neuromuscular, ocular, metabolic and immunological diseases
Highlights
- New on EvolcAdded 2026-11-14
About Entrada Therapeutics
Entrada Therapeutics develops intracellular medicines using its Endosomal Escape Vehicle (EEV) platform, designed to deliver therapeutics into cells and reach disease-causing targets. Its development programs use RNA, antibodies and enzymes.
The company is based in Boston, Massachusetts. Its pipeline includes clinical-stage programs, including oligonucleotide programs for Duchenne muscular dystrophy and a partnered program for myotonic dystrophy type 1.
Product: Develops EEV-based intracellular therapeutics using RNA, antibodies and enzymes for diseases including Duchenne muscular dystrophy.
Jobs at Entrada Therapeutics
More biotech & pharma companies
Erasca
Clinical-stage precision oncology company developing therapies that target the RAS/MAPK cancer signaling pathwayNew on EvolcEVERY™
Animal-free egg white protein ingredients (OvoPro) made by precision fermentation for food manufacturers and foodserviceNew on EvolcFaeth Therapeutics
Develops oral cancer drug candidates targeting multiple nodes in the PI3K/AKT/mTOR pathwayNew on EvolcFieldstone Bio
Biological mineral sensing and mapping tools for mining exploration and operations teamsNew on EvolcForge Biologics
AAV gene therapy development and manufacturing services for biotechnology companies and gene therapy developersNew on EvolcFormation Bio
AI-driven pharmaceutical company acquiring and developing clinical-stage drugs to bring treatments to patients fasterNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
